SA PRO
Free Account
Themes
Edwards Lifesciences CorporationEWNYSE
Loading
OverviewIntelligenceChartsNews

Analyst Sentiment

Analysts lean bullish — 75% recommend buying.

Consensus Rating
Buy
20 analysts·High coverage
75%
Rating Distribution
Strong Buy
00%
Buy
1575%
Hold
525%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 13% higher.

Bear Case
$87.00
+2%
Consensus
$96.38
+13%
Bull Case
$110.00
+29%
Price Range20 analysts
Low
Consensus
High
$87.00
$110.00
Current Target
Current Price
$85.28
Upside to Target
$11.10

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Feb 11, 2026Truist Financial
Edwards Lifesciences price target lowered to $89 from $92 at Truist
Target:$89.00
+15.8%from $76.85
Feb 11, 2026Goldman Sachs
Edwards Lifesciences price target lowered to $95 from $108 at Goldman Sachs
Target:$95.00
+23.3%from $77.05
Feb 11, 2026Piper Sandler
Edwards Lifesciences price target raised to $100 from $98 at Piper Sandler
Target:$100.00
+29.8%from $77.05
Feb 4, 2026UBS
Edwards Lifesciences price target lowered to $94 from $95 at UBS
Target:$94.00
+15.2%from $81.63
Jan 20, 2026Stifel Nicolaus
Edwards Lifesciences price target raised to $110 from $105 at Stifel
Target:$110.00
+30.4%from $84.35
Jan 20, 2026Piper Sandler
Edwards Lifesciences price target raised to $98 from $95 at Piper Sandler
Target:$98.00
+16.2%from $84.35
Jan 12, 2026UBS
Edwards Lifesciences price target raised to $95 from $92 at UBS
Target:$95.00
+13.7%from $83.58
Jan 12, 2026Robert W. Baird
Edwards Lifesciences price target raised to $90 from $87 at Baird
Target:$90.00
+7.5%from $83.69
Jan 12, 2026Barclays
Edwards Lifesciences price target raised to $104 from $103 at Barclays
Target:$104.00
+22.2%from $85.13
Jan 9, 2026Goldman Sachs
Edwards Lifesciences price target raised to $108 from $104 at Goldman Sachs
Target:$108.00
+27.7%from $84.58
Jan 7, 2026Stifel Nicolaus
Edwards Lifesciences price target raised to $105 from $100 at Stifel
Target:$105.00
+22.3%from $85.85
Jan 5, 2026Evercore ISI
Edwards Lifesciences price target raised to $94 from $92 at Evercore ISI
Target:$94.00
+11.4%from $84.34
Dec 18, 2025Wells Fargo
JPMorgan Upgrades Edwards Lifesciences (EW) to Overweight
Target:$100.00
+17.9%from $84.84
Dec 17, 2025Canaccord Genuity
Edwards Lifesciences price target lowered to $87 from $89 at Canaccord
Target:$87.00
+2.0%from $85.32
Dec 16, 2025Robert W. Baird
Edwards Lifesciences price target lowered to $87 from $88 at Baird
Target:$87.00
+4.3%from $83.38
Dec 8, 2025Barclays
Edwards Lifesciences price target raised to $103 from $99 at Barclays
Target:$103.00
+19.5%from $86.19
Dec 5, 2025UBS
Edwards Lifesciences price target raised to $92 from $90 at UBS
Target:$92.00
+6.3%from $86.58
Dec 5, 2025RBC Capital
Edwards Lifesciences (EW) PT Raised at RBC Capital; 'A Catalyst Rich Year in 2026 and Beyond'
Target:$100.00
+14.5%from $87.33
Dec 5, 2025Robert W. Baird
Edwards Lifesciences price target raised to $88 from $83 at Baird
Target:$88.00
+2.6%from $85.78
Dec 5, 2025Canaccord Genuity
Edwards Lifesciences price target raised to $89 from $84 at Canaccord
Target:$89.00
+3.8%from $85.78
Dec 5, 2025Wells Fargo
Edwards Lifesciences price target raised to $96 from $95 at Wells Fargo
Target:$96.00
+11.9%from $85.78
Dec 5, 2025Stifel Nicolaus
Edwards Lifesciences (EW) PT Raised to $100 at Stifel
Target:$100.00
+16.6%from $85.78
Dec 5, 2025Truist Financial
Edwards Lifesciences (EW) PT Raised to $92 at Truist Securities
Target:$92.00
+7.3%from $85.78
Dec 4, 2025BTIG
Edwards Lifesciences price target raised to $103 from $100 at BTIG
Target:$103.00
+20.1%from $85.78
Nov 3, 2025Bernstein
Edwards Lifesciences (EW) PT Raised to $90 at Bernstein After a 'Strong Beat'
Target:$90.00
+9.2%from $82.45

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance